Trials / Completed
CompletedNCT01913613
REDUCE LAP-HF TRIAL
REDUCE LAP-HF TRIAL: A Study to Evaluate the DC Devices, Inc. IASD™ System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Corvia Medical · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this clinical study is to evaluate the safety and performance of the IASD System II in the treatment of heart failure patients with elevated left atrial pressure, who remain symptomatic despite appropriate medical management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | IASD | IASD device implantation |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2015-12-01
- Completion
- 2018-07-01
- First posted
- 2013-08-01
- Last updated
- 2020-07-15
Locations
26 sites across 11 countries: Australia, Austria, Belgium, Czechia, Denmark, France, Germany, Netherlands, New Zealand, Poland, United Kingdom
Source: ClinicalTrials.gov record NCT01913613. Inclusion in this directory is not an endorsement.